{
    "1722713787856257425": {
        "author_id": "194037150",
        "created_at": "2023-11-09T20:32:28.000Z",
        "edit_history_tweet_ids": [
            "1722713787856257425"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 22,
                    "normalized_text": "Patrick",
                    "probability": 0.6614,
                    "start": 16,
                    "type": "Person"
                },
                {
                    "end": 42,
                    "normalized_text": "Novo Nordisk",
                    "probability": 0.6293,
                    "start": 31,
                    "type": "Organization"
                }
            ],
            "mentions": [
                {
                    "end": 12,
                    "id": "34166050",
                    "start": 0,
                    "username": "patrickf121"
                }
            ]
        },
        "id": "1722713787856257425",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 22,
            "like_count": 0,
            "quote_count": 0,
            "reply_count": 0,
            "retweet_count": 0
        },
        "text": "@patrickf121 Hi Patrick.\u00a0While Novo Nordisk is delivering more products than ever, we are experiencing supply constraints for some of our products. This is driven by higher-than-expected demand and temporary capacity limitations at some of our manufacturing sites. (1/3)"
    }
}